File(s) under permanent embargo
A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy
Version 2 2024-06-05, 08:48Version 2 2024-06-05, 08:48
Version 1 2020-09-04, 14:11Version 1 2020-09-04, 14:11
journal contribution
posted on 2024-06-05, 08:48 authored by DL Carey, D Baker, Gary RogersGary Rogers, K Petoumenos, J Chuah, N Easey, K Machon, DA Cooper, S Emery, A CarrA randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy
History
Journal
Journal of Acquired Immune Deficiency SyndromesVolume
46Pagination
581-589Location
Los Angeles, CAPublisher DOI
ISSN
1525-4135eISSN
1077-9450Language
EnglishPublication classification
C1.1 Refereed article in a scholarly journalIssue
5Publisher
LIPPINCOTT WILLIAMS & WILKINSUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicineImmunologyInfectious DiseasesHIVlipoatrophypoly-L-lactic acidACTIVE ANTIRETROVIRAL THERAPYPOLYLACTIC ACIDINFECTED PATIENTSAUTOLOGOUS FATDOUBLE-BLINDLIPODYSTROPHYROSIGLITAZONESUBSTITUTIONINJECTIONSADHERENCE110399 Clinical Sciences not elsewhere classified
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC